Whatever you do, don’t call it a festival. There’s no set schedule or events during the two-day gathering, warns Dave Shenkman, owner of Kite Connection on the Huntington Beach Pier and ...

Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

Lucas Hunter loves to kite surf, so along with his sister Sophie he planned a trip to Colombia to take advantage of the “good waves” in the north of the country in late December last year.

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off ...

Then came the threats of tariffs that the Indian pharma sector could face in the United States. How turbulent could the after-effects be of the possible tariffs? “The key strength of Indian ...

Kennedy Jr. — who also happens to now run the Department of Health and Human Services — have castigated the pharma sector for its all-too-cozy relationship with the FDA, including its penchant ...

Feb 19 (Reuters) - U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official confirmed to Reuters on Wednesday, as the industry tries to ...

curb hospital drug markups and clamp down on pharma middlemen. Regarding innovation, PhRMA says it will encourage the government to protect intellectual property at home and abroad, modernize the ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...

Indian drugmakers earn a significant share of revenue from the U.S., the largest importer of Indian pharma products. India's pharma exports to the country stood at $8.73 billion in fiscal 2024 - a ...

HONG KONG -- U.S. President Donald Trump's latest threat to impose steep blanket tariffs on a range of imports that includes drugs underscores another key friction point in the economic rivalry ...